" /> Autologous Anti-PRAME TCR/CD8alphabeta-expressing T-cells IMA203CD8 - CISMeF





Preferred Label : Autologous Anti-PRAME TCR/CD8alphabeta-expressing T-cells IMA203CD8;

NCIt synonyms : Autologous Anti-PRAME TCR/CD8ab-expressing T-cells IMA203CD8;

NCIt definition : A preparation of autologous T-lymphocytes that are genetically modified with a lentiviral vector encoding a T-cell receptor (TCR) specific for the tumor-associated antigen (TAA) preferentially expressed antigen in melanoma (PRAME) and a CD8alphabeta (CD8ab) co-receptor, with potential immunostimulating and antineoplastic activities. Upon administration back into the patient, the autologous anti-PRAME TCR/CD8ab-expressing T-cells IMA203CD8 specifically recognize and bind to PRAME expressed on cancer cells, which induces a cytotoxic T-lymphocyte (CTL)-mediated immune response against the PRAME-expressing cancer cells. PRAME is overexpressed by a variety of cancer cell types. Co-expression of the CD8ab heterodimer may enhance anti-tumor immune response by engaging CD4 T-cells.;

Molecule name : IMA 203CD8; IMA-203CD8;

NCI Metathesaurus CUI : CL1793924;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.